Exact Mass: 588.4389659999999

Exact Mass Matches: 588.4389659999999

Found 500 metabolites which its exact mass value is equals to given mass value 588.4389659999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tripoxyrollin

3-{12-[3-(2-{3-[2-(3-decyloxiran-2-yl)ethyl]oxiran-2-yl}ethyl)oxiran-2-yl]dodecyl}-5-methyl-2,5-dihydrofuran-2-one

C37H64O5 (588.4753494)


Tripoxyrollin is found in fruits. Tripoxyrollin is a constituent of Annona reticulata (custard apple). Constituent of Annona reticulata (custard apple). Tripoxyrollin is found in fruits.

   

Sanguisorbin B

1,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C35H56O7 (588.4025826)


Sanguisorbin B is found in herbs and spices. Sanguisorbin B is a constituent of burnet bloodwort (Sanguisorba officinalis). Constituent of burnet bloodwort (Sanguisorba officinalis). Sanguisorbin B is found in herbs and spices.

   

Caffeoylcycloartenol

7,7,12,16-Tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

C39H56O4 (588.4178376)


Caffeoylcycloartenol is found in cereals and cereal products. Caffeoylcycloartenol is a constituent of Phalaris canariensis (canary grass). Constituent of Phalaris canariensis (canary grass). Caffeoylcycloartenol is found in cereals and cereal products.

   

22-Angeloyltheasapogenol A

3,5,10-Trihydroxy-4a,9-bis(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicen-4-yl (2Z)-2-methylbut-2-enoic acid

C35H56O7 (588.4025826)


22-Angeloyltheasapogenol A is found in tea. 22-Angeloyltheasapogenol A is a constituent of Assam tea (Camellia sinensis var. assamica) seeds. Constituent of Assam tea (Camellia sinensis variety assamica) seeds. 22-Angeloyltheasapogenol A is found in tea.

   

Lansioside C

3-[2-(2-{5,5,8a-trimethyl-2-methylidene-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-hexahydro-1H-naphthalen-1-yl}ethyl)-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

C35H56O7 (588.4025826)


Lansioside C is found in fruits. Lansioside C is from Lansium domesticum (langsat From Lansium domesticum (langsat). Lansioside C is found in fruits.

   

DG(14:0/20:4(5Z,8Z,11Z,14Z)/0:0)

(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

C37H64O5 (588.4753494)


DG(14:0/20:4(5Z,8Z,11Z,14Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:0/20:4(5Z,8Z,11Z,14Z)/0:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the arachidonic acid moiety is derived from animal fats and eggs. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(14:0/20:4(8Z,11Z,14Z,17Z)/0:0)

(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C37H64O5 (588.4753494)


DG(14:0/20:4(8Z,11Z,14Z,17Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:0/20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicsoatetraenoic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the eicsoatetraenoic acid moiety is derived from fish oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(14:1(9Z)/20:3(5Z,8Z,11Z)/0:0)

(2S)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (5Z,8Z,11Z)-icosa-5,8,11-trienoate

C37H64O5 (588.4753494)


DG(14:1(9Z)/20:3(5Z,8Z,11Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:1(9Z)/20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of mead acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the mead acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(14:1(9Z)/20:3(8Z,11Z,14Z)/0:0)

(2S)-1-hydroxy-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (8Z,11Z,14Z)-icosa-8,11,14-trienoate

C37H64O5 (588.4753494)


DG(14:1(9Z)/20:3(8Z,11Z,14Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:1(9Z)/20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0)

(2S)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H64O5 (588.4753494)


DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearidonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearidonic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearidonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearidonic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0)

(2S)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (6Z,9Z,12Z)-octadeca-6,9,12-trienoate

C37H64O5 (588.4753494)


DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of g-linolenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the g-linolenic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0)

(2S)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H64O5 (588.4753494)


DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0)

(2S)-2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropyl (6Z,9Z,12Z)-octadeca-6,9,12-trienoate

C37H64O5 (588.4753494)


DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9Z,12Z,15Z)/16:1(9Z)/0:0)

(2S)-2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H64O5 (588.4753494)


DG(18:3(9Z,12Z,15Z)/16:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:3(9Z,12Z,15Z)/16:1(9Z)/0:0), in particular, consists of one chain of a-linolenic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0)

(2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H64O5 (588.4753494)


DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The stearidonic acid moiety is derived from seed oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0), in particular, consists of one chain of stearidonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The stearidonic acid moiety is derived from seed oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0)

(2S)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propyl (5Z,8Z,11Z)-icosa-5,8,11-trienoate

C37H64O5 (588.4753494)


DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position. DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

DG(20:3(8Z,11Z,14Z)/14:1(9Z)/0:0)

(2S)-3-hydroxy-2-[(9Z)-tetradec-9-enoyloxy]propyl (8Z,11Z,14Z)-icosa-8,11,14-trienoate

C37H64O5 (588.4753494)


DG(20:3(8Z,11Z,14Z)/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:3(8Z,11Z,14Z)/14:1(9Z)/0:0), in particular, consists of one chain of homo-g-linolenic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The homo-g-linolenic acid moiety is derived from fish oils, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(20:4(5Z,8Z,11Z,14Z)/14:0/0:0)

(2S)-3-hydroxy-2-(tetradecanoyloxy)propyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

C37H64O5 (588.4753494)


DG(20:4(5Z,8Z,11Z,14Z)/14:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:4(5Z,8Z,11Z,14Z)/14:0/0:0), in particular, consists of one chain of arachidonic acid at the C-1 position and one chain of myristic acid at the C-2 position. The arachidonic acid moiety is derived from animal fats and eggs, while the myristic acid moiety is derived from nutmeg and butter. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(20:4(8Z,11Z,14Z,17Z)/14:0/0:0)

(2S)-3-hydroxy-2-(tetradecanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C37H64O5 (588.4753494)


DG(20:4(8Z,11Z,14Z,17Z)/14:0/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:4(8Z,11Z,14Z,17Z)/14:0/0:0), in particular, consists of one chain of eicsoatetraenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. The eicsoatetraenoic acid moiety is derived from fish oils, while the myristic acid moiety is derived from nutmeg and butter. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

   

DG(14:0/0:0/20:4n6)

(2R)-2-Hydroxy-3-(tetradecanoyloxy)propyl (8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid

C37H64O5 (588.4753494)


DG(14:0/0:0/20:4n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:0/0:0/20:4n6), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidonic acid at the C-3 position. The myristic acid moiety is derived from nutmeg and butter, while the arachidonic acid moiety is derived from animal fats and eggs. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(14:0/0:0/20:4n3)

(2R)-2-hydroxy-3-(tetradecanoyloxy)propyl (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C37H64O5 (588.4753494)


DG(14:0/0:0/20:4n3) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:0/0:0/20:4n3), in particular, consists of one chain of myristic acid at the C-1 position and one chain of eicosatetraenoic acid at the C-3 position. The myristic acid moiety is derived from nutmeg and butter, while the eicosatetraenoic acid moiety is derived from fish oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(16:0/0:0/18:4n3)

(2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H64O5 (588.4753494)


DG(16:0/0:0/18:4n3) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(16:0/0:0/18:4n3), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearidonic acid at the C-3 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearidonic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(14:1n5/0:0/20:3n9)

(2R)-2-Hydroxy-3-[(5Z)-tetradec-5-enoyloxy]propyl (5Z,11Z)-icosa-5,8,11-trienoic acid

C37H64O5 (588.4753494)


DG(14:1n5/0:0/20:3n9) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:1n5/0:0/20:3n9), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of mead acid at the C-3 position. The myristoleic acid moiety is derived from milk fats, while the mead acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(14:1n5/0:0/20:3n6)

(2S)-2-Hydroxy-3-[(5Z)-tetradec-5-enoyloxy]propyl (8Z,11Z,14Z)-icosa-8,11,14-trienoic acid

C37H64O5 (588.4753494)


DG(14:1n5/0:0/20:3n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(14:1n5/0:0/20:3n6), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of homo-g-linolenic acid at the C-3 position. The myristoleic acid moiety is derived from milk fats, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(16:1n7/0:0/18:3n6)

(2R)-3-[(7Z)-Hexadec-7-enoyloxy]-2-hydroxypropyl (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid

C37H64O5 (588.4753494)


DG(16:1n7/0:0/18:3n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(16:1n7/0:0/18:3n6), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of g-linolenic acid at the C-3 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the g-linolenic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(16:1n7/0:0/18:3n3)

(2S)-3-[(7Z)-Hexadec-7-enoyloxy]-2-hydroxypropyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid

C37H64O5 (588.4753494)


DG(16:1n7/0:0/18:3n3) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(16:1n7/0:0/18:3n3), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of a-linolenic acid at the C-3 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C35H56O7 (588.4025826)


DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C35H56O7 (588.4025826)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-3-(decanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C35H56O7 (588.4025826)


DG(10:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/10:0)

(2S)-3-(decanoyloxy)-2-hydroxypropyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C35H56O7 (588.4025826)


DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C35H56O7 (588.4025826)


DG(10:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C35H56O7 (588.4025826)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-3-(decanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C35H56O7 (588.4025826)


DG(10:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C35H56O7 (588.4025826)


DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

(2S)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Basilimoside

(2R,3R,4S,5S,6R)-2-{[(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,3E)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


Basilimoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Basilimoside can be found in sweet basil, which makes basilimoside a potential biomarker for the consumption of this food product.

   

O-Tigloylgymnemagenin

[(3R,4R,4aR,5S,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-4,5,10-trihydroxy-4a,9-bis(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicen-3-yl] (E)-2-methylbut-2-enoate

C35H56O7 (588.4025826)


   
   

3-O-(E)-Coumaroyl erythrodiol

3-O-(E)-Coumaroyl erythrodiol

C39H56O4 (588.4178376)


   

3-(Z)-Caffeoyllupeol

3-(Z)-Caffeoyllupeol

C39H56O4 (588.4178376)


A pentacyclic triterpenoid that is the cinnamate ester obtained by the formal condensation of the carboxylic group of cis-caffeic acid with the hydroxy group of lupeol (the 3beta stereoisomer). It is isolated from the fruits of Bruguiera parviflora and exhibits antimalarial activity.

   

3-O-(E)-p-Coumaroylbetulin

3-O-(E)-p-Coumaroylbetulin

C39H56O4 (588.4178376)


   

(3S,4R,5S,6S,4S,5S,6S)-5,6,5,6-Tetrahydro-beta,beta-carotene-3,4,4-triol

(3S,4R,5S,6S,4S,5S,6S)-5,6,5,6-Tetrahydro-beta,beta-carotene-3,4,4-triol

C40H60O3 (588.454221)


   
   

Argentinic acid B

Argentinic acid B

C35H56O7 (588.4025826)


   

acutifloric acid

acutifloric acid

C40H60O3 (588.454221)


   

Caffeoylcycloartenol

7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecan-6-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

22-hydroxytaraxeryl-cis-p-coumarate

22-hydroxytaraxeryl-cis-p-coumarate

C39H56O4 (588.4178376)


   

22-Tigloyl -(3beta,15alpha,16alpha,21beta,22alpha)-12-Oleanene-3,15,16,21,22,28-hexol

22-Tigloyl -(3beta,15alpha,16alpha,21beta,22alpha)-12-Oleanene-3,15,16,21,22,28-hexol

C35H56O7 (588.4025826)


   

21-O-Tigloylgymnemagenin

21-O-Tigloylgymnemagenin

C35H56O7 (588.4025826)


   
   

21-Angeloyl -(3beta,15alpha,16alpha,21beta,22alpha)-12-Oleanene-3,15,16,21,22,28-hexol|21-O-Angeloyl-R1-barrigenol (21beta-Angeloyloxy-3beta,15alpha,16alpha,22alpha,28-pentahydroxy-oleanen-(12))

21-Angeloyl -(3beta,15alpha,16alpha,21beta,22alpha)-12-Oleanene-3,15,16,21,22,28-hexol|21-O-Angeloyl-R1-barrigenol (21beta-Angeloyloxy-3beta,15alpha,16alpha,22alpha,28-pentahydroxy-oleanen-(12))

C35H56O7 (588.4025826)


   

3??-(Z)-Caffeoyltaraxerol

3??-(Z)-Caffeoyltaraxerol

C39H56O4 (588.4178376)


   

alpha-amyrin-3-O-beta-D-glucopyranoside

alpha-amyrin-3-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   
   

(3beta,16beta)-16-hydroxyolean-19-en-3-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate

(3beta,16beta)-16-hydroxyolean-19-en-3-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

Stigmasterol ferulate

Stigmasterol ferulate

C39H56O4 (588.4178376)


   

(3beta,16beta)-16-hydroxylup-20(29)-en-3-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate

(3beta,16beta)-16-hydroxylup-20(29)-en-3-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

3-Malonyl,12-Ac-Dammar-24-ene-3,12,20-triol

3-Malonyl,12-Ac-Dammar-24-ene-3,12,20-triol

C35H56O7 (588.4025826)


   
   

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   
   

12-oleanaen-3beta-caffeate

12-oleanaen-3beta-caffeate

C39H56O4 (588.4178376)


   

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

C36H60O6 (588.4389659999999)


   

3beta,15alpha,21beta,22alpha,28-pentahydroxy-16alpha-angeloyloxy-Delta12-oleanene

3beta,15alpha,21beta,22alpha,28-pentahydroxy-16alpha-angeloyloxy-Delta12-oleanene

C35H56O7 (588.4025826)


   

makisterone C 2,3;20,22-diacetonide|rel-(1S,3aS,5aR,6aR,9aS,10aR,10bR,12aR)-1-[(4R,5R)-5-[(2R)-2-ethyl-3-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-1,2,3a,5a,6,6a,9a,10,10a,10b,11,12,12a-tetradecahydro-3a-hydroxy-8,8,10a,12a-tetramethyl-5H-cyclopenta[7,8]phenanthro[2,3-d][1,3]dioxol-5-one

makisterone C 2,3;20,22-diacetonide|rel-(1S,3aS,5aR,6aR,9aS,10aR,10bR,12aR)-1-[(4R,5R)-5-[(2R)-2-ethyl-3-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-1,2,3a,5a,6,6a,9a,10,10a,10b,11,12,12a-tetradecahydro-3a-hydroxy-8,8,10a,12a-tetramethyl-5H-cyclopenta[7,8]phenanthro[2,3-d][1,3]dioxol-5-one

C35H56O7 (588.4025826)


   

7-oxostigmasta-5,25-diene-3-O-beta-D-glucopyranoside

7-oxostigmasta-5,25-diene-3-O-beta-D-glucopyranoside

C35H56O7 (588.4025826)


   

5alpha-methoxy-(22E)-ergosta-7,9,22-trien-3beta-ol beta-D-glucoside|easitoerol 5

5alpha-methoxy-(22E)-ergosta-7,9,22-trien-3beta-ol beta-D-glucoside|easitoerol 5

C35H56O7 (588.4025826)


   

3beta-(E)-p-coumaroylnepeticin

3beta-(E)-p-coumaroylnepeticin

C39H56O4 (588.4178376)


   

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

3alpha-(E)-p-coumaroyloxyfriedelan-7-one

3alpha-(E)-p-coumaroyloxyfriedelan-7-one

C39H56O4 (588.4178376)


   

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

C36H60O6 (588.4389659999999)


   

Lansioside C

3-[2-(2-{5,5,8a-trimethyl-2-methylidene-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-decahydronaphthalen-1-yl}ethyl)-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

C35H56O7 (588.4025826)


   

3-O-(6-deoxy-beta-D-glucopyranosyl)pyrocincholic acid|inermiside II

3-O-(6-deoxy-beta-D-glucopyranosyl)pyrocincholic acid|inermiside II

C35H56O7 (588.4025826)


   

7-oxostigmasteryl-3-O-beta-D-glucopynoside|7-oxostigmasteryl-3-O-beta-D-glucopyranoside

7-oxostigmasteryl-3-O-beta-D-glucopynoside|7-oxostigmasteryl-3-O-beta-D-glucopyranoside

C35H56O7 (588.4025826)


   

O-Acetylpachymic acid-25-ol

O-Acetylpachymic acid-25-ol

C35H56O7 (588.4025826)


   

cycloeucalenol trans-ferulate

cycloeucalenol trans-ferulate

C39H56O4 (588.4178376)


   

Caffeoxylupeol

(3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl) (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

DG(17:2/17:2/0:0)

1,2-di-(9Z,12Z-heptadecadienoyl)-sn-glycerol

C37H64O5 (588.4753494)


   

DG(16:1/18:3/0:0)[iso2]

1-(9Z-hexadecenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycerol

C37H64O5 (588.4753494)


   

Diglyceride

1-homo-gamma-linolenoyl-2-myristoleoyl-sn-glycerol

C37H64O5 (588.4753494)


   

22-Angeloyltheasapogenol A

3,5,10-trihydroxy-4a,9-bis(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicen-4-yl (2Z)-2-methylbut-2-enoate

C35H56O7 (588.4025826)


   

Sanguisorbin B

1,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

Tripoxyrollin

3-{12-[3-(2-{3-[2-(3-decyloxiran-2-yl)ethyl]oxiran-2-yl}ethyl)oxiran-2-yl]dodecyl}-5-methyl-2,5-dihydrofuran-2-one

C37H64O5 (588.4753494)


   

DG(12:0/22:4(7Z,10Z,13Z,16Z)/0:0)[iso2]

1-dodecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol

C37H64O5 (588.4753494)


   

3-O-alpha-L-rhamnopyranosyl-3-hydroxypalmitoyl-3-hydroxydecanoic acid

3-O-alpha-L-rhamnopyranosyl-3-hydroxyhexadecanoyl-3-hydroxydecanoic acid

C32H60O9 (588.423711)


   

DG 34:4

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-hexadecanoyl-sn-glycerol

C37H64O5 (588.4753494)


   

3-O-L-AO

3beta-O-alpha-L-arabinosyl hydroxyolean-12-en-28-oic acid

C35H56O7 (588.4025826)


   

3,4,4-Trihydroxypirardixanthin

(3S,4R,5S,6S,4S,5S,6S)-5,6,5,6-Tetrahydro-beta,beta-carotene-3,4,4-triol

C40H60O3 (588.454221)


   
   

5,11,17,23-tetrakis-dimethylaminomethylcalix[4!arene

5,11,17,23-tetrakis-dimethylaminomethylcalix[4!arene

C40H52N4 (588.4191752)


   

dodecyl 2-methylprop-2-enoate,ethyl 2-methylprop-2-enoate,2-hydroxyethyl prop-2-enoate,styrene

dodecyl 2-methylprop-2-enoate,ethyl 2-methylprop-2-enoate,2-hydroxyethyl prop-2-enoate,styrene

C35H56O7 (588.4025826)


   

trinonyl benzene-1,2,4-tricarboxylate

trinonyl benzene-1,2,4-tricarboxylate

C36H60O6 (588.4389659999999)


   

1-Myristoyl-3-eicsoatetraenoyl-sn-glycerol

1-Myristoyl-3-eicsoatetraenoyl-sn-glycerol

C37H64O5 (588.4753494)


   

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(10:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C35H56O7 (588.4025826)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/10:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/10:0/0:0)

C35H56O7 (588.4025826)


   

DG(10:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(10:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C35H56O7 (588.4025826)


   

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/10:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/10:0)

C35H56O7 (588.4025826)


   

DG(10:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(10:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C35H56O7 (588.4025826)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/10:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/10:0/0:0)

C35H56O7 (588.4025826)


   

DG(10:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(10:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C35H56O7 (588.4025826)


   

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/10:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/10:0)

C35H56O7 (588.4025826)


   

1-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9R,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3R,9R,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9S,10R)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   

1-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

1-[(3S,9S,10S)-9-[[cyclohexylmethyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea

C33H56N4O5 (588.4250486)


   
   
   
   
   
   
   

Mgdg O-14:1_9:0

Mgdg O-14:1_9:0

C32H60O9 (588.423711)


   

Mgdg O-19:1_4:0

Mgdg O-19:1_4:0

C32H60O9 (588.423711)


   

Mgdg O-15:1_8:0

Mgdg O-15:1_8:0

C32H60O9 (588.423711)


   

Mgdg O-20:1_3:0

Mgdg O-20:1_3:0

C32H60O9 (588.423711)


   

Mgdg O-21:1_2:0

Mgdg O-21:1_2:0

C32H60O9 (588.423711)


   

Mgdg O-8:0_15:1

Mgdg O-8:0_15:1

C32H60O9 (588.423711)


   

Mgdg O-17:1_6:0

Mgdg O-17:1_6:0

C32H60O9 (588.423711)


   

Mgdg O-18:1_5:0

Mgdg O-18:1_5:0

C32H60O9 (588.423711)


   

Mgdg O-9:0_14:1

Mgdg O-9:0_14:1

C32H60O9 (588.423711)


   

Mgdg O-16:1_7:0

Mgdg O-16:1_7:0

C32H60O9 (588.423711)


   

Mgdg O-13:1_10:0

Mgdg O-13:1_10:0

C32H60O9 (588.423711)


   

Mgdg O-10:0_13:1

Mgdg O-10:0_13:1

C32H60O9 (588.423711)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(4E,8E)-2-(heptanoylamino)-3-hydroxynonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(heptanoylamino)-3-hydroxynonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(pentanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(pentanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(octanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(octanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-2-(butanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(butanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-2-(hexanoylamino)-3-hydroxyicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(hexanoylamino)-3-hydroxyicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(nonanoylamino)heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(nonanoylamino)heptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(propanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(propanoylamino)tricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-2-acetamido-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-acetamido-3-hydroxytetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

4-(12-hydroxy-10,13-dimethyl-3-tridecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

4-(12-hydroxy-10,13-dimethyl-3-tridecanoyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

C37H64O5 (588.4753494)


   

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(undecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(undecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-octanoyloxypropyl] octanoate

[3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]-2-octanoyloxypropyl] octanoate

C37H64O5 (588.4753494)


   

(2-octanoyloxy-3-octoxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(2-octanoyloxy-3-octoxypropyl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H64O5 (588.4753494)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C36H60O6 (588.4389659999999)


   

(2-decanoyloxy-3-octoxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-decanoyloxy-3-octoxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H64O5 (588.4753494)


   

(3-decoxy-2-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(3-decoxy-2-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H64O5 (588.4753494)


   

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-octanoyloxypropyl] decanoate

[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-octanoyloxypropyl] decanoate

C37H64O5 (588.4753494)


   

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C37H64O5 (588.4753494)


   

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

(1-dodecanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C37H64O5 (588.4753494)


   

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

(1-hexadecanoyloxy-3-hydroxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H64O5 (588.4753494)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] (Z)-octadec-9-enoate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] (Z)-octadec-9-enoate

C37H64O5 (588.4753494)


   

(1-decanoyloxy-3-hydroxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

(1-decanoyloxy-3-hydroxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C37H64O5 (588.4753494)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C37H64O5 (588.4753494)


   

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C37H64O5 (588.4753494)


   

(1-hydroxy-3-tetradecanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

(1-hydroxy-3-tetradecanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C37H64O5 (588.4753494)


   

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] octadecanoate

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] octadecanoate

C37H64O5 (588.4753494)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C37H64O5 (588.4753494)


   

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[1-carboxy-3-[2-hydroxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(7E,10E,13E,16E,19E,22E)-pentacosa-7,10,13,16,19,22-hexaenoyl]oxypropoxy]propyl]-trimethylazanium

C35H58NO6+ (588.4263908)


   

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxytetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(2S,3R,4E,6E)-2-(decanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,6E)-2-(decanoylamino)-3-hydroxyhexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyhexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C31H61N2O6P (588.4267015999999)


   

2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H59NO7P+ (588.4028934)


   

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C31H59NO7P+ (588.4028934)


   

2-[Carboxy-(3-nonanoyloxy-2-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-nonanoyloxy-2-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C32H62NO8+ (588.4475192)


   

2-[Carboxy-(3-octanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-octanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C32H62NO8+ (588.4475192)


   

2-[[2-heptanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C31H59NO7P+ (588.4028934)


   

2-[Carboxy-[2,3-di(undecanoyloxy)propoxy]methoxy]ethyl-trimethylazanium

2-[Carboxy-[2,3-di(undecanoyloxy)propoxy]methoxy]ethyl-trimethylazanium

C32H62NO8+ (588.4475192)


   

2-[Carboxy-(3-decanoyloxy-2-dodecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

2-[Carboxy-(3-decanoyloxy-2-dodecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C32H62NO8+ (588.4475192)


   

TG(33:4)

TG(16:0_6:0_11:4)

C36H60O6 (588.4389659999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 13:3/O-26:7

FAHFA 13:3/O-26:7

C39H56O4 (588.4178376)


   

FAHFA 13:4/O-26:6

FAHFA 13:4/O-26:6

C39H56O4 (588.4178376)


   

FAHFA 14:3/O-25:7

FAHFA 14:3/O-25:7

C39H56O4 (588.4178376)


   

FAHFA 14:4/O-25:6

FAHFA 14:4/O-25:6

C39H56O4 (588.4178376)


   

FAHFA 15:3/O-24:7

FAHFA 15:3/O-24:7

C39H56O4 (588.4178376)


   

FAHFA 15:4/O-24:6

FAHFA 15:4/O-24:6

C39H56O4 (588.4178376)


   

FAHFA 15:5/O-24:5

FAHFA 15:5/O-24:5

C39H56O4 (588.4178376)


   

FAHFA 16:3/O-23:7

FAHFA 16:3/O-23:7

C39H56O4 (588.4178376)


   

FAHFA 16:4/O-23:6

FAHFA 16:4/O-23:6

C39H56O4 (588.4178376)


   

FAHFA 16:5/O-23:5

FAHFA 16:5/O-23:5

C39H56O4 (588.4178376)


   

FAHFA 17:3/O-22:7

FAHFA 17:3/O-22:7

C39H56O4 (588.4178376)


   

FAHFA 17:4/O-22:6

FAHFA 17:4/O-22:6

C39H56O4 (588.4178376)


   

FAHFA 17:5/O-22:5

FAHFA 17:5/O-22:5

C39H56O4 (588.4178376)


   

FAHFA 18:3/O-21:7

FAHFA 18:3/O-21:7

C39H56O4 (588.4178376)


   

FAHFA 18:4/O-21:6

FAHFA 18:4/O-21:6

C39H56O4 (588.4178376)


   

FAHFA 18:5/O-21:5

FAHFA 18:5/O-21:5

C39H56O4 (588.4178376)


   

FAHFA 18:6/O-21:4

FAHFA 18:6/O-21:4

C39H56O4 (588.4178376)


   

FAHFA 19:4/O-20:6

FAHFA 19:4/O-20:6

C39H56O4 (588.4178376)


   

FAHFA 19:5/O-20:5

FAHFA 19:5/O-20:5

C39H56O4 (588.4178376)


   

FAHFA 19:6/O-20:4

FAHFA 19:6/O-20:4

C39H56O4 (588.4178376)


   

FAHFA 20:4/O-19:6

FAHFA 20:4/O-19:6

C39H56O4 (588.4178376)


   

FAHFA 20:5/O-19:5

FAHFA 20:5/O-19:5

C39H56O4 (588.4178376)


   

FAHFA 20:6/O-19:4

FAHFA 20:6/O-19:4

C39H56O4 (588.4178376)


   

FAHFA 21:4/O-18:6

FAHFA 21:4/O-18:6

C39H56O4 (588.4178376)


   

FAHFA 21:5/O-18:5

FAHFA 21:5/O-18:5

C39H56O4 (588.4178376)


   

FAHFA 21:6/O-18:4

FAHFA 21:6/O-18:4

C39H56O4 (588.4178376)


   

FAHFA 21:7/O-18:3

FAHFA 21:7/O-18:3

C39H56O4 (588.4178376)


   

FAHFA 22:5/O-17:5

FAHFA 22:5/O-17:5

C39H56O4 (588.4178376)


   

FAHFA 22:6/O-17:4

FAHFA 22:6/O-17:4

C39H56O4 (588.4178376)


   

FAHFA 22:7/O-17:3

FAHFA 22:7/O-17:3

C39H56O4 (588.4178376)


   

FAHFA 23:5/O-16:5

FAHFA 23:5/O-16:5

C39H56O4 (588.4178376)


   

FAHFA 23:6/O-16:4

FAHFA 23:6/O-16:4

C39H56O4 (588.4178376)


   

FAHFA 23:7/O-16:3

FAHFA 23:7/O-16:3

C39H56O4 (588.4178376)


   

FAHFA 24:5/O-15:5

FAHFA 24:5/O-15:5

C39H56O4 (588.4178376)


   

FAHFA 24:6/O-15:4

FAHFA 24:6/O-15:4

C39H56O4 (588.4178376)


   

FAHFA 24:7/O-15:3

FAHFA 24:7/O-15:3

C39H56O4 (588.4178376)


   

FAHFA 25:6/O-14:4

FAHFA 25:6/O-14:4

C39H56O4 (588.4178376)


   

FAHFA 25:7/O-14:3

FAHFA 25:7/O-14:3

C39H56O4 (588.4178376)


   

FAHFA 26:6/O-13:4

FAHFA 26:6/O-13:4

C39H56O4 (588.4178376)


   

FAHFA 26:7/O-13:3

FAHFA 26:7/O-13:3

C39H56O4 (588.4178376)


   
   
   
   
   
   
   
   

PA P-14:0/15:1 or PA O-14:1/15:1

PA P-14:0/15:1 or PA O-14:1/15:1

C32H61O7P (588.4154685999999)


   
   

PA P-16:1/13:0 or PA O-16:2/13:0

PA P-16:1/13:0 or PA O-16:2/13:0

C32H61O7P (588.4154685999999)


   
   

PA P-18:1/11:0 or PA O-18:2/11:0

PA P-18:1/11:0 or PA O-18:2/11:0

C32H61O7P (588.4154685999999)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3ar,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1r,3ar,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3e,5e,11e,13e)-16-[(6e)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(3e,5e,11e,13e)-16-[(6e)-3,9-dihydroxy-4,8,10-trimethyl-5-oxoundec-6-en-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C35H56O7 (588.4025826)


   

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

01eanolic acid-3-0-β-D-xylopy-ranoside

NA

C35H56O7 (588.4025826)


{"Ingredient_id": "HBIN000001","Ingredient_name": "01eanolic acid-3-0-\u03b2-D-xylopy-ranoside","Alias": "NA","Ingredient_formula": "C35H56O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36493","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

11-p-coumaroylnepeticin

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN000517","Ingredient_name": "11-p-coumaroylnepeticin","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "NA","Ingredient_weight": "588.869","OB_score": "NA","CAS_id": "161984-15-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9379","PubChem_id": "NA","DrugBank_id": "NA"}

   

22α-O-angeloy-barrigenolA1

NA

C35H56O7 (588.4025826)


{"Ingredient_id": "HBIN003681","Ingredient_name": "22\u03b1-O-angeloy-barrigenolA1","Alias": "NA","Ingredient_formula": "C35H56O7","Ingredient_Smile": "CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)O)C)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

22-o-angeloyl theasapogenol a

NA

C35H56O7 (588.4025826)


{"Ingredient_id": "HBIN003745","Ingredient_name": "22-o-angeloyl theasapogenol a","Alias": "NA","Ingredient_formula": "C35H56O7","Ingredient_Smile": "CC=C(C)C(=O)OC1C(C(CC2C1(C(CC3(C2=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C)O)CO)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1235","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3β-(e)-caffeoyltaraxerol

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN008212","Ingredient_name": "3\u03b2-(e)-caffeoyltaraxerol","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2926","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3β-(z)-caffeoyltaraxerol

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN008340","Ingredient_name": "3\u03b2-(z)-caffeoyltaraxerol","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2927","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-(e)-caffeoyllupeol

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN008457","Ingredient_name": "3-(e)-caffeoyllupeol","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2910","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-o-α-l-arabinopyranosyloleanolicacid

NA

C35H56O7 (588.4025826)


{"Ingredient_id": "HBIN009073","Ingredient_name": "3-o-\u03b1-l-arabinopyranosyloleanolicacid","Alias": "NA","Ingredient_formula": "C35H56O7","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1C)C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1576","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-o-β-d-xylopyranosyloleanolicacid

NA

C35H56O7 (588.4025826)


{"Ingredient_id": "HBIN009266","Ingredient_name": "3-o-\u03b2-d-xylopyranosyloleanolicacid","Alias": "NA","Ingredient_formula": "C35H56O7","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22823","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-o-(e)-coumaroylerythrodiol

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN009319","Ingredient_name": "3-o-(e)-coumaroylerythrodiol","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)CO)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4155","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-o-(z)-coumaroylerythrodiol

NA

C39H56O4 (588.4178376)


{"Ingredient_id": "HBIN009444","Ingredient_name": "3-o-(z)-coumaroylerythrodiol","Alias": "NA","Ingredient_formula": "C39H56O4","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)CO)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4156","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

4-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

4-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylhept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11bs,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3as,5ar,5br,7ar,9s,11ar,11bs,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(2s,3s,5r)-5-[(1r)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl (2e)-2-methylbut-2-enoate

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(2s,3s,5r)-5-[(1r)-1,2-dihydroxy-2-methylpropyl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl (2e)-2-methylbut-2-enoate

C35H56O7 (588.4025826)


   

8-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

8-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H56O7 (588.4025826)


   

4-[(1r)-2-[(1r,2s,4as,8as)-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]-1-hydroxyethyl]-2-[(1e)-2-[(1r,2s,4as,8as)-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]ethenyl]benzaldehyde

4-[(1r)-2-[(1r,2s,4as,8as)-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]-1-hydroxyethyl]-2-[(1e)-2-[(1r,2s,4as,8as)-5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl]ethenyl]benzaldehyde

C39H56O4 (588.4178376)


   

4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

2,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

2,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

(3s,4ar,6ar,6br,8s,8as,12bs,14ar,14br)-8-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6br,8s,8as,12bs,14ar,14br)-8-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12b,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

3-[2-(2-{5,5,8a-trimethyl-2-methylidene-6-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]-hexahydro-1h-naphthalen-1-yl}ethyl)-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

3-[2-(2-{5,5,8a-trimethyl-2-methylidene-6-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]-hexahydro-1h-naphthalen-1-yl}ethyl)-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

C35H56O7 (588.4025826)


   

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3s,4ar,6ar,6bs,8as,12ar,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6bs,8as,12ar,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

2,2,6b,9,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

2,2,6b,9,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(1r,1'r,4's,5'r,9's,10's,13'r)-4-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

(1r,1'r,4's,5'r,9's,10's,13'r)-4-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C40H60O3 (588.454221)


   

stigmasteryl ferulate

stigmasteryl ferulate

C39H56O4 (588.4178376)


   

(1r,3as,5ar,5br,7as,9s,11ar,11bs,13as,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3as,5ar,5br,7as,9s,11ar,11bs,13as,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3ar,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1r,3ar,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(1r,3as,4s,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-4-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3as,4s,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-4-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3s,4ar,6ar,6bs,8as,12ar,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6bs,8as,12ar,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

1-(5-ethyl-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-one

C35H56O7 (588.4025826)


   

(3ar,5ar,5br,7ar,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

(3ar,5ar,5br,7ar,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1s,2r,3s,4s)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,5s,6s)-5-hydroxy-2,2,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohexane-1,2-diol

(1s,2r,3s,4s)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,5s,6s)-5-hydroxy-2,2,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohexane-1,2-diol

C40H60O3 (588.454221)


   

(1s,4s,5r,6s,9r,10r,11r,12r,14r)-4,5,6-trihydroxy-11-(hydroxymethyl)-3,11,14-trimethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl hexadecanoate

(1s,4s,5r,6s,9r,10r,11r,12r,14r)-4,5,6-trihydroxy-11-(hydroxymethyl)-3,11,14-trimethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-7-yl hexadecanoate

C35H56O7 (588.4025826)


   

3-[2-(2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl)-1-hydroxy-2-oxoethyl]-7-ethenyl-4b,7,10a-trimethyl-1-methylidene-octahydro-3h-phenanthren-2-one

3-[2-(2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl)-1-hydroxy-2-oxoethyl]-7-ethenyl-4b,7,10a-trimethyl-1-methylidene-octahydro-3h-phenanthren-2-one

C40H60O3 (588.454221)


   

4-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

4-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C40H60O3 (588.454221)


   

(3r,4r,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-3,5,6,10-tetrahydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2z)-2-methylbut-2-enoate

(3r,4r,4ar,5s,6r,6as,6br,8ar,10s,12ar,12br,14bs)-3,5,6,10-tetrahydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl (2z)-2-methylbut-2-enoate

C35H56O7 (588.4025826)


   

4-(2-{5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl}-1-hydroxyethyl)-2-(2-{5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl}ethenyl)benzaldehyde

4-(2-{5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl}-1-hydroxyethyl)-2-(2-{5,5,8a-trimethyl-hexahydro-1h-spiro[naphthalene-2,2'-oxiran]-1-yl}ethenyl)benzaldehyde

C39H56O4 (588.4178376)


   

17-[5-(2-ethyl-3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-14-hydroxy-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

17-[5-(2-ethyl-3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-14-hydroxy-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

C35H56O7 (588.4025826)


   

8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

(1s,1'r,4'r,5's,9'r,10'r,13'r)-4-{2-[(1s,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

(1s,1'r,4'r,5's,9'r,10'r,13'r)-4-{2-[(1s,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C40H60O3 (588.454221)


   

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[(1s,3ar,3br,5ar,7r,9ar,9br,11r,11ar)-11-(acetyloxy)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O7 (588.4025826)


   

3-[(3s,3as,5ar,6s,7r,9r,9ar)-9-{[(2r)-2-hydroxy-3-methylbutanoyl]oxy}-7-(2-hydroxypropan-2-yl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoic acid

3-[(3s,3as,5ar,6s,7r,9r,9ar)-9-{[(2r)-2-hydroxy-3-methylbutanoyl]oxy}-7-(2-hydroxypropan-2-yl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoic acid

C35H56O7 (588.4025826)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

3,5,6,10-tetrahydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 2-methylbut-2-enoate

3,5,6,10-tetrahydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl 2-methylbut-2-enoate

C35H56O7 (588.4025826)


   

15-[5-(1,2-dihydroxy-2-methylpropyl)-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 2-methylbut-2-enoate

15-[5-(1,2-dihydroxy-2-methylpropyl)-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 2-methylbut-2-enoate

C35H56O7 (588.4025826)


   

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(3s,4as,4br,7r,8ar,10ar)-3-[(1r)-2-[(2s,4ar,4br,8ar)-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl]-1-hydroxy-2-oxoethyl]-7-ethenyl-4b,7,10a-trimethyl-1-methylidene-octahydro-3h-phenanthren-2-one

(3s,4as,4br,7r,8ar,10ar)-3-[(1r)-2-[(2s,4ar,4br,8ar)-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl]-1-hydroxy-2-oxoethyl]-7-ethenyl-4b,7,10a-trimethyl-1-methylidene-octahydro-3h-phenanthren-2-one

C40H60O3 (588.454221)


   

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(4as,6br,12ar)-2,2,6b,9,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(4as,6br,12ar)-2,2,6b,9,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)


   

3-{[11-(acetyloxy)-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

3-{[11-(acetyloxy)-1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-3-oxopropanoic acid

C35H56O7 (588.4025826)


   

3-[(1s,2s,6s)-2-{2-[(1s,4ar,6s,8ar)-5,5,8a-trimethyl-2-methylidene-6-{[(2r,3r,4r,5r)-3,4,5-trihydroxyoxolan-2-yl]methoxy}-hexahydro-1h-naphthalen-1-yl]ethyl}-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

3-[(1s,2s,6s)-2-{2-[(1s,4ar,6s,8ar)-5,5,8a-trimethyl-2-methylidene-6-{[(2r,3r,4r,5r)-3,4,5-trihydroxyoxolan-2-yl]methoxy}-hexahydro-1h-naphthalen-1-yl]ethyl}-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid

C35H56O7 (588.4025826)


   

(4as,6br,8ar,10s,12ar,12br,14bs)-2,2,6b,9,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(4as,6br,8ar,10s,12ar,12br,14bs)-2,2,6b,9,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C35H56O7 (588.4025826)


   

(1r,2r,4s,8r,10r,14s,17s,18r)-17-[(4r,5r)-5-[(2r)-2-ethyl-3-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-14-hydroxy-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

(1r,2r,4s,8r,10r,14s,17s,18r)-17-[(4r,5r)-5-[(2r)-2-ethyl-3-hydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-14-hydroxy-2,6,6,18-tetramethyl-5,7-dioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-12-en-11-one

C35H56O7 (588.4025826)


   

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O4 (588.4178376)